欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1225/001
药品名称Leustatin 2 mg/ml
活性成分
    • Cladribine 2.0 mg/ml
剂型Solution for injection
上市许可持有人Atnahs Pharma Netherlands B.V. Oerestads Boulevard 108 5 Tv 2300 Copenhagen S Denmark
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Czechia (CZ)
      Leustatin 2 mg/ml injekční roztok
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Austria (AT)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
      Leuject
    • Hungary (HU)
      Leustatin 2 mg/ml oldatos injekció
    • Bulgaria (BG)
许可日期2024/09/12
最近更新日期2025/01/08
药物ATC编码
    • L01BB04 cladribine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase